Delivery Order SPE2DB22D3301-SPE2DB24FY3LE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $6,781.27 delivery order is for the supply of 4,564,222,014 units of Granisetron HCL 1 mg Tablet UD 20s, a generic antiemetic medication. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,162.26, is for the delivery of granisetron HCL 1 mg tablet units. It is a firm fixed-price delivery order contract with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron Hydrochloride 1 mg tablets. The $7,864.04 firm fixed-price contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award, valued at $3,256.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Granisetron Hydrochloride 1 mg tablets in blister packs of 20, with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this firm fixed price delivery order. The company also holds an indefinite delivery contract (IDC) with DLA, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron Hydrochloride 1 mg Tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,346.21, and has an ultimate completion date of October 19, 2023. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,674.06 firm fixed-price delivery order is for the supply of 4560863588 - Granisetron HCL 1 mg Tablet UD 20s, with a completion date of May 9, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, with an ID of SPE2DX15D3006|SPE2DX24F03TQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,598.70, is a delivery order for the supply of Granisetron HCl 1 mg tablets. It is a firm fixed-price contract with a completion date of July 2, 2024. The contract does not have any set-aside designation, indicating open...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,046.92 contract is for the supply of 4,563,631,434 units of the pharmaceutical drug Granisetron Hydrochloride 1 mg Tablets. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,622.80, for the supply of Granisetron Hydrochloride 1 mg Tablets. The contract has an ultimate completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Granisetron HCL 1 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $16,393.09. The contract has an ultimate completion date of November 14, 2024 and is a Firm Fixed Price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY3LEDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,564.18 firm fixed price delivery order is for the supply of 4,564,094,914 units of the medication Granisetron HCL 1 mg Tablet UD 20s. This award is associated with Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 3/27/24 |